Siren, L.L.C. Spring Works Therapeutics, Inc. Put Options Transaction History
Siren, L.L.C.
- $2 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
230Shares Held
70MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.71MShares$233 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$195 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$133 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$122 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$119 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.17B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...